
    
      The purpose of the study is to understand the effect of lowering serum uric acid levels on
      vascular function in individuals with chronic kidney disease by comparing the effects of:

      1) Allopurinol therapy and 2) Placebo.

      Patients will receive: 3 month study drug (either allopurinol or placebo), with assessment of
      serum uric acid levels and vascular function.
    
  